News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
Bowel cancer study reveals impact of mutations on protein networks
For the first time, scientists have completed a detailed study of many of the proteins in bowel cancer cells.
Professor Johann de Bono to chair NCRI Cancer Conference
The ICR’s Professor Johann de Bono will take the prestigious position of Chair of the Scientific Committee for the 2017 National Cancer Research Institute (NCRI) annual conference in Liverpool this November.
Tributes for pioneering ICR radiotherapy scientist Dr Roy Bentley
Researchers at the Institute of Cancer Research, London, have paid tribute to their former colleague and radiotherapy pioneer Dr Roy Bentley, who sadly died last month.
Scientists uncover a deadly ‘addiction’ in oesophageal cancer
Scientists have discovered a new way of attacking oesophageal cancer cells that could make use of an existing drug in a new approach to treatment.
Patients with advanced cancer survive 10 years on first targeted cancer wonder drug
A significant minority of patients with advanced and aggressive cancer have survived more than 10 years after treatment with one of the first successful targeted cancer drugs.
Non-invasive imaging test could predict which kidney cancer patients will benefit from anti-vascular therapy
A magnetic resonance imaging test that measures the volume of blood in tumours could help select which patients will benefit from drugs that block blood vessel growth, a new study shows.
New tests select patients who could live for nearly a year longer on targeted bowel cancer drug
Giving patients with bowel cancer an MRI scan and a blood test could pick out those who would benefit from a targeted cancer treatment, a new study reports.
Scientists find new method to target hard-to-treat head and neck cancers
An MRI technique could help doctors predict survival and develop improved treatments by identifying areas of fluctuating oxygen levels in head and neck tumours.
Testing for immune ‘hotspots’ can predict risk that breast cancer will return
Scientists have developed a new test that can pick out women at high risk of relapsing from breast cancer within 10 years of diagnosis.
Targeted radiotherapy limits side effects of breast cancer treatment
Breast cancer patients who have radiotherapy targeted at the original tumour site experience fewer side effects five years after treatment than those who have whole breast radiotherapy, according to trial results published in The Lancet.
Structure of key complex behind DNA transcription uncovered
Researchers have determined the structure of a molecular protein complex that helps DNA to be read and its instructions carried out.
Discovery Club learns of “lost tribe” of young adult cancer patients
Members of our Discovery Club gathered at Chelsea Physic Garden in London earlier this month to learn about the unique challenges posed in treating cancer in teens and young adults.
